Stockreport

Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com
PDF SEATTLE Dec. 15, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. ( Nasdaq ATOS Atossa " or the "Company"), a clinical-stage biopharmaceutical company developing innovati [Read more]